Workflow
AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.
艾伯维艾伯维(US:ABBV) Prnewswire·2025-09-30 19:00

Accessibility StatementSkip Navigation NORTH CHICAGO, Ill., Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of a 70millionexpansionatitsAbbVieBioresearchCenter(ABC)inWorcester,Mass.,whichservesasacenterofexcellenceforbiologicsresearchanddevelopmentandmanufacturing.Thisexpansionispartofthecompany′spreviouslyannouncedcommitmenttoinvestmorethanA^70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than 10 billion of capital in the U.S. to broadly support innovation and expand criti ...